ProShare Advisors
LUNG icon

ProShare Advisors’s Pulmonx LUNG Stock Holding History

ProShare Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,669
Closed -$72.4K – 2181
2024
Q4 		$72.4K Buy
+10,669
New +$70.3K ﹤0.01% 2127
2021
Q3 		– Sell
-6,589
Closed -$291K – 2144
2021
Q2 		$291K Buy
+6,589
New +$287K ﹤0.01% 1914

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's LUNG Position: Q1 2025 in Review

ProShare Advisors sold out of Pulmonx (LUNG) in Q1 2025, closing a stake of 10,669 shares — an estimated $72.4K sold.

ProShare Advisors first reported a position in LUNG in Q2 2021 and held it in 2 quarters. The position peaked at $291K in Q2 2021. 115 funds tracked by Wall St. Rank hold LUNG as of Q1 2025.

  • ProShare Advisors reported no remaining Pulmonx position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,669 Pulmonx shares in Q1 2025, an estimated $72.4K.
  • ProShare Advisors first reported a position in Pulmonx in Q2 2021 and held it in 2 quarters.
  • ProShare Advisors's Pulmonx position peaked at $291K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.